No Data
No Data
Novavax Updates Financial Terms With Takeda for Covid-19 Vaccine Agreement in Japan
B. Riley Cuts Price Target on Novavax to $18 From $22, Keeps Buy Rating
Express News | Novavax Inc - Updated Agreement Includes Upfront Payment and Annual Milestones Related to Regulatory Approvals & Royalties on Net Sales Earned
Express News | Novavax Inc - Nuvaxovid to Remain Available in Japan
Express News | Novavax Announces Significantly Improved Terms for Collaboration and License Agreement With Takeda for Nuvaxovid® in Japan
Novavax Announces Significantly Improved Terms for Collaboration and License Agreement With Takeda for Nuvaxovid in Japan